Louise Slater is a team leader at Cancer Research Horizons, overseeing a Cell Biology team developing assays for antibodies to oncology targets. Previously, Louise served as a Senior Scientist at Cancer Research UK - AstraZeneca Antibody Alliance Laboratory and as a Postdoctoral Fellow at MedImmune. Louise conducted their Ph.D. in Chemical Biology at Harvard University and also worked as a Teaching Fellow at the same institution. Louise's research background includes investigating cancer-associated fibroblasts, anthrax lethal toxin intoxication, and folding characteristics of human lysozyme.
December, 2020 - present